Xcout Intel
LabGenius competitors & alternatives
The 12 closest competitors and alternatives to LabGenius among biotech companies — ranked by similarity to what LabGenius actually does, not by market-cap band.
Subscribe to see LabGenius’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About LabGenius
LabGenius Ltd is a biotechnology company (also known as LabGenius Therapeutics) that utilizes machine learning and automation to discover and develop novel protein therapeutics. The company collaborates with major pharmaceutical partners, such as LG Chem, to advance research and development activities.
LabGenius at a glance
LabGenius is a biotech company headquartered in United Kingdom, founded in 2012. It has raised at least $47.2M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $44.5M in May 2024. Xcout tracks 18 named people at LabGenius, including Angus Sinclair (Chief Scientific Officer).
LabGenius leadership
- Angus SinclairChief Scientific Officer
- Hannah SeitzChief Business Officer
- Edwin MosesChairman
- James FieldChief Executive Officer
- Catherine HowshamVP, Projects and Portfolio Delivery
- Edward de MoravilleVP, Finance
12 more named people on record for LabGenius, with roles, board committees and tenure — see the full roster →
LabGenius funding rounds
At least $47.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $44.5M | 7 named | |
| SEC Form D filing | $2.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 LabGenius competitors
Ranked by semantic similarity — how close each company is to LabGenius by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Biotechnology
Engine Biosciences is a Singapore-based biotechnology company and venture-creation platform that combines machine learning, computational biology, and laboratory experimentation to discover and develop new medicines. It builds and invests in therapeutic-focused biotech companies, serving pharmaceutical and healthcare markets.
Biotechnology
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
Biotechnology
Biolojic Design is an Israeli biotechnology company that uses computational modeling and artificial intelligence to design and engineer antibodies and other therapeutic proteins. It develops drug candidates and collaborates with pharmaceutical and biotechnology companies seeking novel biologic medicines.
Similar biotech company
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
Similar biotech company
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Similar biotech company
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Similar biotech company
Metis TechBio Co., Ltd., founded in 2020 and headquartered in Beijing, China, (previously Hangzhou Jitai Pharmaceutical Technology Co., Ltd.) specializes in the advanced research and development of AI-powered nanomaterials. The company's core mission is to facilitate the delivery and application of active agents within carbon-based life forms, operating in both the Chinese Mainland and the United States. Central to its offerings is NanoForge, a comprehensive suite of interconnected technologies that includes a novel lipid library, foundational artificial intelligence models, METiSAIAgent, cutting-edge quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. Furthermore, Metis TechBio has developed specialized platforms like AiTEM, AiLNP, and AiRNA. These tools are crucial for simulating, predicting, and interpreting interactions at the nanoscale, thereby enabling the precise design, optimization, and validation of sophisticated nanomaterials and their associated payloads. The company provides its services through a three-tiered system: a foundational dry-wet data layer supported by integrated laboratory infrastructure, a model layer featuring METiS AI foundational models, and an application layer known as METiSAgentv. Metis TechBio primarily serves a diverse clientele, including pharmaceutical companies, biotechnology firms, and medical research institutions.
Similar biotech company
Harmonic Discovery is a drug discovery company founded in 2021 and headquartered in New York City. The company leverages machine learning and precision pharmacology to develop therapeutics for complex diseases.
Biotechnology
Reverie Labs is a Cambridge, Massachusetts-based biotechnology company founded in 2017 that applied machine learning to drug discovery and developed brain-penetrant cancer therapies. In its operations, the company focused on accelerating preclinical drug development through lead generation and optimization using machine learning models and software.
Biotechnology
Genesis Therapeutics, Inc. is an active for-profit biotechnology company founded by Ben Sklaroff and Evan Feinberg. The company specializes in leveraging artificial intelligence for molecular discovery and drug development with operations in California and Delaware.
Similar biotech company
Healx is an AI-native pharmaceutical company that uses artificial intelligence and technology to discover and develop new treatments for rare diseases. The company redevelops, combines, and enhances known compounds to build a drug pipeline aimed at delivering effective therapies to patients.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of LabGenius and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for LabGeniusand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →